Rohto Pharmaceutical Co (TSE:4527) 3-Year EBITDA Growth Rate : 13.70% (As of Dec. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co 3-Year EBITDA Growth Rate?

Rohto Pharmaceutical Co's EBITDA per Share for the three months ended in Dec. 2023 was 円61.62.

During the past 12 months, Rohto Pharmaceutical Co's average EBITDA Per Share Growth Rate was 21.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 13.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Rohto Pharmaceutical Co was 16.20% per year. The lowest was 0.80% per year. And the median was 4.00% per year.

Competitive Comparison of Rohto Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rohto Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Rohto Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Rohto Pharmaceutical Co (TSE:4527) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Rohto Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Rohto Pharmaceutical Co (TSE:4527) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

4527:Mexico

Address

1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666

Website

https://www.rohto.co.jp

Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines